Plasma levels of TNF-α and IL-6 are inversely related to cytochrome P450-dependent drug metabolism in patients with congestive heart failure

Journal of Cardiac Failure

Volumn 8, Issue 5, 2002, Pages 315-319

  Frye, Reginald F ^a   Schneider, Virginia M ^b   Frye, Carole S ^b   Feldman, Arthur M ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Cytochrome P450; Drugs; Interleukins; Pharmacogenetics

Indexed keywords

CAFFEINE; CHLORZOXAZONE; CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2C19; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; DEXTROMETHORPHAN; DRUG METABOLITE; INTERLEUKIN 6; MEPHENYTOIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEART FAILURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL; URINE LEVEL;

EID: 0036774272     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1054/jcaf.2002.127773     Document Type: Article

References (15)

1. Abernethy DR, Flockhart DA: Molecular basis of cardiovascular drug metabolism: Implications for predicting clinically important drug interactions. Circulation 2000;101(14):1749-1753.
2. Wrighton SA, Stevens JC: The human hepatic cytochromes P450 involved in drug metabolism. Crit Rev Toxicol 1992;22(1):1-21.
3. Mann DL, Young JB: Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines. Chest 1994;105(3):897-904.
4. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL: Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the Studies of Left Ventricular Dysfunction (SOLVD). J Amer Coll Cardiol 1996;27(5):1201-1206.
5. Feldman AM, Combes A, Wagner D, Kadakomi T, Kubota T, Li YY, McTiernan C: The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol 2000;35(3):537-544.
6. Morgan ET: Regulation of cytochromes P450 during inflammation and infection. Drug Metab Rev 1997;29(4):1129-1188.
7. Frye RF, Matzke GR, Adedoyin A, Porter J, Branch RA: Validation of the Pittsburgh cocktail approach to assess selective regulation of drug metabolizing enzymes. Clin Pharmacol Ther 1997;62(4):365-376.
8. Chen ZR, Somogyi AA, Bochner F: Simultaneous determination of dextromethorphan and three metabolites in plasma and urine using high-performance liquid chromatography with application to their disposition in man. Ther Drug Monit 1990;12:97-104.
9. De Morais SM, Goldstein JA, Xie HG, Huang SL, Lu YQ, Xia H, Xiao ZS, Ile N, Zhou HH: Genetic analysis of the S-mephenytoin polymorphism in a Chinese population. Clin Pharmacol Ther 1995;58(4):404-411.
10. Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM, Newman AB, Nevitt M, Harris TB: Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: The Health ABC Study. J Gerontol A Biol Sci Med Sci 2002;57(5):M326-M332.
11. Angus PW, Ng CY, Ghabrial H, Morgan DJ, Smallwood RA: Effects of chronic left ventricular failure on hepatic oxygenation and theophylline elimination in the rat. Drug Metab Dispos 1995;23(4):485-489.
12. Glassman AH, Johnson LL, Giardina EG, Walsh BT, Roose SP, Cooper TB, Bigger JT Jr: The use of imipramine in depressed patients with congestive heart failure. J Amer Med Assoc 1983;250(15):1997-2001.
13. Song JC, White CM: Pharmacologic, pharmacokinetic, and therapeutic differences among angiotensin II receptor antagonists. Pharmacotherapy 2000;20(2):130-139.
14. CHF Studies of ENBREL (Entracept) Will Conclude Early, Monitoring Board Advises Study Not Likely To Meet Efficacy Endpoints (Press Release). Wyeth. Accessed September 10, 2002. URL: http://www.wyeth.com/news/Pressed_and_Released/pr03_22_2001_164.asp? archive=2001.
15. Deckelbaum LI, Important drug warning (letter). Centocor. Accessed September 10, 2002. URL: http://www. fda.gov/medwatch/safety/2001/remicade_deardoc.pdf.